Finally, miR‐29a up‐regulation is associated with dismal clinical outcomes and with repression of TET‐SOCS1‐matrix metalloproteinase (MMP) 9 axis in HCC patients. This evidence concerns the gene SOCS1 and hepatocellular carcinoma.